期刊文献+

上调基因-4在结肠癌中的表达及临床意义 被引量:4

Expression of up-regulated gene-4 in colon cancer and its clinicopathologic significance
原文传递
导出
摘要 目的探讨上调基因-4(up-regulated gene-4,URG-4)在结肠癌及其癌旁组织中的表达及临床意义。方法收集2010年1-6月本院手术切除的82例结肠癌、癌旁组织样本及石蜡切片标本,用RT-PCR、免疫组化检测URG-4基因的转录和表达情况,分析其与临床病理参数的关系。结果结肠癌组织中的URG-4 mRNA阳性率为85.37%(70/82),显著高于癌旁组织中的36.59%(30/82)(P<0.01)。URG-4蛋白在结肠癌中的表达率为70.73%(58/82),癌旁组织为24.39%(20/82),两组比较差异非常显著(P<0.01);肿瘤组织中URG-4的表达与患者的年龄、性别、肿瘤的分化程度、有无远处转移无明显相关性(P>0.05),而与浸润深度及淋巴结转移显著相关(P<0.01)。结论与癌旁组织相比URG-4在结肠癌中高表达,并且URG-4表达强度与肿瘤浸润深度和淋巴结转移呈正相关,提示其可能在结肠癌的发生、发展中起重要作用。 Objective To investigate the expression of up-regulated gene-4(URG-4) in colon cancer tissues and adjacent non-cancerous tissues and its clinicopathologic significance.Methods Paraffin-embedded and liquid-nitrogen-preserved specimens of colon cancer tissues and adjacent non-cancerous tissues were prepared from 82 colon cancer patients in our hospital from January to June in 2010.Expression of URG-4 mRNA and protein was detected by reverse transcription PCR(RT-PCR) and immunohistochemical staining,and its correlation with clinicopathologic features was analyzed.Results The positive rate of URG-4 mRNA expression in colon cancer tissues(85.73%,70/82) was significantly higher than that in adjacent non-cancerous tissues(36.59%,30/82)(P0.01).The expression rate of URG-4 protein in colon cancer tissues(70.73%,58/82) was significantly higher than that in adjacent non-cancerous tissues(24.39%,20/82)(P0.01).In addition,the expression of URG-4 protein was positively related to tumor infiltration depth and lymph node metastasis(P0.01),while no correlation was found between the expression of URG-4 protein and age,gender,tumor differentiation and distant metastasis(P0.05).Conclusion The expression of URG-4 mRNA and protein in colon cancer tissues is significantly higher than that in adjacent non-cancerous tissues.Besides,it is positively correlated with tumor infiltration depth and lymph node metastasis in colon cancer.The results indicate that URG-4 plays an important role in colon cancer development.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2011年第1期33-35,共3页 Journal of Third Military Medical University
基金 全军医学科研"十一五"计划面上项目(06MB243)~~
关键词 上调基因-4 结肠癌 RT-PCR 免疫组化 up-regulated gene-4 colon cancer RT-PCR immunohistochemistry
  • 相关文献

参考文献2

二级参考文献50

  • 1Stewart BW,Kleihues P,eds.World Cancer Report.IARC non-serial publication.Lyon:IARC,2003.
  • 2Washington MK.Colorectal carcinoma:selected issues in pathologic examination and staging and determination of prognostic factors.Arch Pathol Lab Med 2008; 132:1600-1607.
  • 3Midgley RS,Yanagisawa Y,Kerr DJ.Evolution of nonsurgical therapy for colorectal cancer.Nat Clin Pract Gastroenterol Hepatol 2009; 6:108-120.
  • 4Glimelius B.Benefit-risk assessment of irinotecan in advanced colorectal cancer.Drug Saf 2005; 28:417-433.
  • 5Cunningham D,Pyrh.nen S,James RD,Punt CJ,Hickish TF,Heikkila R,Johannesen TB,Starkhammar H,Topham CA,Awad L,Jacques C,Herait P.Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer.Lancet 1998; 352:1413-1418.
  • 6Rougier P,Van Cutsem E,Bajetta E,Niederle N,Possinger K,Labianca R,Navarro M,Morant R,Bleiberg H,Wils J,Awad L,Herait P,Jacques C.Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer.Lancet 1998; 352:1407-1412.
  • 7Rothenberg ML,Cox JV,DeVore RF,Hainsworth JD,Pazdur R,Rivkin SE,Macdonald JS,Geyer CE Jr,Sandbach J,Wolf DL,Mohrland JS,Elfring GL,Miller LL,Von Hoff DD.A multicenter,phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma.Cancer 1999; 85:786-795.
  • 8Lu C,El-Deiry WS.Targeting p53 for enhanced radio-and chemo-sensitivity.Apoptosis 2009; 14:597-606.
  • 9Lam AK,Ong K,Ho YH.hTERT expression in colorectal adenocarcinoma:correlations with p21,p53 expressions and clinicopathological features.Int J Colorectal Dis 2008; 23:587-594.
  • 10Lam AK,Ong K,Giv MJ,Ho YH.p16 expression in colorectal adenocarcinoma:marker of aggressiveness and morphological types.Pathology 2008; 40:580-585.

共引文献21

同被引文献42

  • 1康玲,来茂德.BTEB/KLF9与基因转录调控[J].遗传,2007,29(5):515-522. 被引量:5
  • 2Tufan NL, Lian Z, Liu J, et al. Hepatitis Bx antigen stimulates expression of a novel cellular gene, URG4, that promotes hepatocellular growth and survival. Neoplasia,2002,4 (4) :355-368.
  • 3Huang J, Zhu B, Lu L, et al. The expression of novel gene URG4 in osteosarcoma : correlation with patients' prognosis. Pathology, 2009,41 (2) :149-154.
  • 4Song J, Xie H, Lian Z, et al. Enhanced cell survival of gastric cancer cells by a novel gene URG4. Neoplasia,2006,8 ( 12 ) :995- 1002.
  • 5Tsang HT, Connell JW, Brown SE, et al. A systematic analysis of human CHMP protein interactions: additional MIT domain-containing proteins bind to multiple components of the human ESCRT III complex. Genomics,2006,88 (3) :333-346.
  • 6Shim JH, Xiao C, Hayden MS, et al. CHMP5 is essential for late endosome function and down-regulation of receptor signaling during mouse embryogenesis. J Cell Biol,2006,172(7) :1045-1056.
  • 7Ward DM, Vaughn MB, Shiflett SL, et al. The role of LIP5 and CHMP5 in muhivesicular body formation and HIV-1 budding in mammalian cells. J Biol Chem,2005,280( 11 ) :10548-10555.
  • 8Shim S, Merrill SA, Hanson PI. Novel interactions of ESCRT-III with LIP5 and VPS4 and their implications for ESCRT-III disassembly. Mol Biol Cell, 2008,19 ( 6 ) : 2661 - 2672.
  • 9Shahmoradgoli M, Mannherz O, Engel F, et al. Antiapoptotic function of charged multivesicular body protein 5 : a potentially relevant gene in acute myeloid leukemia. Int J Cancer,2011,128 (12) :2865-2871.
  • 10Pincetic A, Kuang Z, Seo E J, et al. The interferon-induced gene ISG15 blocks retrovirus release from cells late in the budding process. J Virol,2010,84(9) :4725-4736.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部